Automatic Data Processing (ADP)
(Delayed Data from NSDQ)
$304.73 USD
-0.12 (-0.04%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $304.74 +0.01 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$304.73 USD
-0.12 (-0.04%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $304.74 +0.01 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth B Momentum D VGM
Zacks News
Pre-Markets Down on 4.7% 10-Year; JOLTS Data This Morning
by Mark Vickery
The 10-year bond yield continues to be an albatross around the neck of equities trading, currently bringing returns of 4.71%.
Rollins (ROL) Rides on Strong Operating Platform and Buyouts
by Zacks Equity Research
Shareholder-friendly behavior and a healthy demand situation bode well for Rollins (ROL).
Buyouts and Shareholder-Friendly Policies Aid S&P Global (SPGI)
by Zacks Equity Research
S&P Global (SPGI) is poised to grow due to acquisitions, innovation, and strong cash flow. Decreasing liquidity position is a concern.
Take the Zacks Approach to Beat the Market: Shopify, Caterpillar, Amgen in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
ICF International (ICFI) Rises 12% in Six Months: Here's How
by Zacks Equity Research
Past and future acquisitions are expected to contribute to the growth of ICF International's (ICFI) EBITDA and free cash flow.
Broadridge (BR) Rises 25% in a Year: What You Should Know
by Zacks Equity Research
Broadridge (BR) benefits from its growth strategy in governance, capital markets and wealth management.
Here's Why You Should Retain Interpublic (IPG) Stock for Now
by Zacks Equity Research
Interpublic's (IPG) increasingly diverse workforce gives the company a key competitive edge.
Reasons to Retain Equifax (EFX) Stock in Your Portfolio
by Zacks Equity Research
Equifax's (EFX) ongoing cloud data and technology transformation is aimed at driving innovation and product development.
Accenture (ACN) Surpasses Q4 Earnings Estimates, Rises YoY
by Zacks Equity Research
Accenture's (ACN) improving segmental results helps its earnings and revenues for the fourth quarter to grow year over year.
Paychex's (PAYX) Q1 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Paychex's (PAYX) earnings and revenues grow year over year due to in-demand HR solutions.
5 Safe Stocks to Buy Amid Plummeting U.S. Consumer Confidence
by Nalak Das
We have narrowed our search to five large-cap low-beta stocks with a solid dividend yield. These are: AWK, ADP, KO, KMB, IBM.
Reasons to Hold FactSet (FDS) Stock in Your Portfolio Now
by Zacks Equity Research
FactSet (FDS) has a consistent track record of rewarding its shareholders through share repurchases and dividends.
Here's Why Trane Technologies (TT) Stock is a Great Pick
by Zacks Equity Research
Trane Technologies (TT) seeks to improve its position by enhancing product effectiveness and introducing new products.
Fiserv (FI) Benefits From Financial Efficiency and Product Portfolio
by Zacks Equity Research
Fiserv (FI) gains from a diversified portfolio and increasing efficiency in capital usage amid foreign currency risks.
Here's How Stantec (STN) Gained 38% in the Year-to-Date Period
by Zacks Equity Research
Acquisitions are a significant catalyst for Stantec's (STN) business development.
5 Dividend Aristocrats to Buy as Things Look Dicey for Wall Street
by Tirthankar Chakraborty
As stocks are subjected to bouts of volatility, place bets on dividend aristocrats like Caterpillar (CAT), Abbott Laboratories (ABT), McDonald's (MCD), Aflac (AFL) and Automatic Data Processing (ADP) for steady income.
Here's Why You Should Retain H&R Block (HRB) in Your Portfolio
by Zacks Equity Research
H&R Block (HRB) gains from its Block Horizons 2025 plan, which promises growth, profitability and financial strength ahead. Increasing expenses are concerning.
Aptiv (APTV) Stock Gains 17% in a Year: Here's What to know
by Zacks Equity Research
Aptiv's (APTV) "smart architecture" provides a competitive advantage and should help it continue gaining market share.
Down -5.41% in 4 Weeks, Here's Why You Should You Buy the Dip in ADP (ADP)
by Zacks Equity Research
The heavy selling pressure might have exhausted for ADP (ADP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Xerox's (XRX) Stock Rises 10% in Six Months: Here's How
by Zacks Equity Research
Xerox (XRX) has a post-sale-driven business model that provides significant recurring revenues and cash generation.
Stericycle (SRCL) Stock Rises 10% in 6 Months: Here's How
by Zacks Equity Research
Stericycle (SRCL) is progressing well with its key objectives, including improving the quality of revenues and driving operational efficiency.
FactSet (FDS) Q4 Earnings Miss Estimates, Revenues Surpass
by Zacks Equity Research
FactSet (FDS) witnesses an increase in revenues in the fourth quarter of fiscal 2023, driven by growth in Analytics & Trading and Content & Technology solutions.
Paychex (PAYX) to Report Q1 Earnings: Here's What to Expect
by Zacks Equity Research
Paychex (PAYX) is expected to witness earnings and revenue beat in the first quarter of fiscal 2024 due to the demand for solutions.
Here's What to Expect From Accenture's (ACN) Q4 Results
by Zacks Equity Research
Strong segmental performance mixed with favorable demand and utilization situation are expected to benefit Accenture (ACN) in the fourth quarter of fiscal 2023.
Scoop Up These 4 GARP Stocks to Receive Handsome Returns
by Zacks Equity Research
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. RACE, HUBB, ADP and ARCO are some stocks that hold promise.